SmallCap
CompaniesMapStatistics

투바이오스㈜

Venture Certified
Data Quality: 7/10

Basic Information


Unlisted

Company Name투바이오스㈜
Business Reg. No.6938601348
CEO최영빈
Address서울특별시 성북구
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products의료기기
EstablishedContact
Phone02-742-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.110111-*******

Investment Metrics


Market Cap
-
Op. Margin
-
ROE
-62.87%
Debt Ratio
3%

Certification Status


Venture Certified

Cert. History
기술평가보증기업(기금)2019-10-16 ~ 2021-10-15201901119532019-10-16
벤처투자유형2021-10-16 ~ 2024-10-15202110130100332019-10-16
벤처투자유형2024-10-16 ~ 2027-10-15202410080100202019-10-16

Financial Statements


2-Year Financial Data
Item20232022
Revenue

0.0B

0.0B

Operating Profit

-3.3B

-2.1B

Net Profit

-3.0B

-2.0B

Total Assets

4.9B

7.9B

Total Liabilities

0.1B

0.1B

Total Equity

4.8B

7.8B

Risk Indicators


3 Risk Indicators

Comparison Metrics


vs. Prior Year
Based on 2023
Revenue
0

- 0.0%

vs. Prior Year: 0
Operating Profit
-3B

58.2%

vs. Prior Year: -2B
Debt Ratio
3.0%

149.4%

vs. Prior Year: 1.2%
ROE
-62.9%

150.5%

vs. Prior Year: -25.1%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
최영빈대표이사대표

Employment Status


Regular EmployeesContact
CEO최영빈

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "서울특별시 성북구",
  "ceo_name": "최영빈",
  "certificate": [
    {
      "cert_number": "20190111953",
      "changes": "",
      "disclosure_date": "2019-10-16",
      "first_cert_date": "2019-10-16",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2019-10-16 ~ 2021-10-15"
    },
    {
      "cert_number": "20211013010033",
      "changes": "",
      "disclosure_date": "2021-10-13",
      "first_cert_date": "2019-10-16",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2021-10-16 ~ 2024-10-15"
    },
    {
      "cert_number": "20241008010020",
      "changes": "",
      "disclosure_date": "2024-10-08",
      "first_cert_date": "2019-10-16",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2024-10-16 ~ 2027-10-15"
    }
  ],
  "company_name": "투바이오스㈜",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 12759000,
      "cost_of_sales": 0,
      "current_assets": 701402000,
      "current_liabilities": 9385000,
      "gross_profit": 0,
      "net_income": -195892000,
      "net_income_bs": -195892000,
      "non_current_assets": 88452000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 102639000,
      "non_operating_income": 112134000,
      "operating_profit": -205387000,
      "revenue": 0,
      "sga_expenses": 205387000,
      "total_assets": 789854000,
      "total_equity": 780469000,
      "total_liabilities": 9385000
    },
    "2023": {
      "capital_stock": 12759000,
      "cost_of_sales": 0,
      "current_assets": 367956000,
      "current_liabilities": 14372000,
      "gross_profit": 0,
      "net_income": -301273000,
      "net_income_bs": -301274000,
      "non_current_assets": 125611000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 289671000,
      "non_operating_income": 313404000,
      "operating_profit": -325006000,
      "revenue": 0,
      "sga_expenses": 325006000,
      "total_assets": 493567000,
      "total_equity": 479195000,
      "total_liabilities": 14372000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "300,000,000",
      "changes": "300,000,000",
      "date": "2021-09-17"
    },
    {
      "amount": "300,000,000",
      "changes": "300,000,000",
      "date": "2021-09-17"
    }
  ],
  "main_products": "의료기기",
  "phone": "02-742-****",
  "years": [
    2023,
    2022
  ]
}

Data Sources


Data Quality: 7/10 | Primary Source: Venture System | Section Coverage: 6/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsNot Collected
Not Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
G2B Procurement2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
Employment Insurance2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected